Log In
Sign Up
Cytosine arabinoside, cytarabine
Acute myeloid leukemia (AML) which include - acute promyelocytic, monocytic, myelomonocytic, megakaryoblastic, and erythroid leukemias; acute lymphocytic leukemia (ALL); meningeal leukemia and other meningeal neoplasms; chronic myelogenous leukemia (CML); non-Hodgkin's lymphomas in children; myelodysplastic syndrome. It is used principally as a component of various chemotherapeutic regimens.
100 mg/m2/day by continuous IV infusion from day 1 through 7 or 100 mg/ m2IV every 12 hours day 1 through 7 [in combination with other antineoplastics]. Consult specialist literature for further information.
Mode of action
Side Effects
Pregnancy risk
Special information
Brands containing this Ingredient
Name Form. Strength Pack Price Insert Manufacturer Distributor
Biobin Injection 100mg 1 KES578.00
Cytosar. inj 100mg/5mL 1 KES715.00
Drug Index 2.0 is here
Our new update features a more powerful search feature and easier login. Having any issues? Contact us today. Contact Us